Fluorescence

Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared Fluorescence Visualization, Expanding Application of Existing Robotic Exoscope

Retrieved on: 
Wednesday, March 27, 2024

Near-Infrared fluorescence now available on Modus X robotic exoscope, complementing system’s existing advanced fluorescence capabilities

Key Points: 
  • Near-Infrared fluorescence now available on Modus X robotic exoscope, complementing system’s existing advanced fluorescence capabilities
    TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Synaptive Medical Inc., a global med tech and technology company solving surgical, imaging and data challenges, has received 510(k) clearance from the Food and Drug Administration (FDA) for its Near-Infrared fluorescence visualization module, Modus IR, adding to the existing fluorescence offering on its 4K 3D robotic exoscope, Modus X.
  • Synaptive’s Modus X features a unique fluorescence feature, powered by customized LED lighting, that enables a live fusion of white light and fluorescence views.
  • This enables visualization of fluorescent tissue and surrounding anatomy simultaneously to provide additional anatomical context while performing complex microsurgical techniques.
  • ICG causes blood to fluoresce under infrared light and is used to aid in the visualization of vessels and blood flow.

Rapaport Press Release: Prices of Lower-Clarity Diamonds Rise in March

Retrieved on: 
Tuesday, April 2, 2024

Prices for round, 1-carat, D-H, SI diamonds increased 1.7% in March as the lower-clarity segment saw a correction after last year’s severe declines.

Key Points: 
  • Prices for round, 1-carat, D-H, SI diamonds increased 1.7% in March as the lower-clarity segment saw a correction after last year’s severe declines.
  • Diamonds with no fluorescence or black centers sold at premiums.
  • Group of Seven (G7) sanctions on Russian diamonds over 1 carat went into effect March 1.
  • Many questions about the US sanctions remain, including how the government will treat “grandfathered” diamonds.

STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests

Retrieved on: 
Tuesday, March 26, 2024

STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone Marrow CD138 Positive Selection Kit has been granted de novo classification by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment.

Key Points: 
  • STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone Marrow CD138 Positive Selection Kit has been granted de novo classification by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment.
  • View the full release here: https://www.businesswire.com/news/home/20240326396951/en/
    STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone Marrow CD138 Positive Selection Kit is now classified by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment.
  • (Photo: Business Wire)
    The kit can be used to enrich plasma cells expressing the CD138 marker (CD138+ cells) from patient bone marrow samples.
  • The EasySep™ Human Bone Marrow CD138 Positive Selection Kit will be available for sale in the United States, the European Union, Canada, and the United Kingdom.

Epson Increases Production Efficiency and Productivity for Textile Print Shops with Two New Industrial Dye-Sublimation Printers

Retrieved on: 
Tuesday, April 2, 2024

LOS ALAMITOS, Calif., April 2, 2024 /PRNewswire/ -- The digital textile market has seen rapid growth in recent years and is projected to grow to nearly $3.4 billion in 2024, with a portion of that growth due to the implementation of digital workflows. To help support this increasing demand, Epson today announced two new industrial SureColor® F-Series dye-sublimation printers engineered to achieve both industrial reliability and round-the-clock productivity at a low total cost of ownership. The new models, the SureColor F11070 and SureColor F11070H, are highly productive printers that offer an optional large roll media unwinder, and the SureColor F11070H features an expanded ink set to support high-volume print shops.

Key Points: 
  • To help support this increasing demand, Epson today announced two new industrial SureColor® F-Series dye-sublimation printers engineered to achieve both industrial reliability and round-the-clock productivity at a low total cost of ownership.
  • Epson announces the SureColor F11070 and F11070H dye-sublimation printers to support high-volume print shops.
  • "The Epson SureColor F-Series sets the benchmark for textile printers, offering unmatched reliability and exceptional image quality.
  • These new high-speed industrial models are built for productivity, enabling round-the-clock production for print shops.

UbiQD's Quantum Dot Greenhouse Technology Wins 2024 SXSW Innovation Award and U.S. Department of Agriculture SBIR Grant

Retrieved on: 
Tuesday, March 19, 2024

LOS ALAMOS, N.M., March 19, 2024 /PRNewswire/ -- UbiQD, Inc., the New Mexico-based leader in quantum dot (QD) technology and manufacturing, announced today that it was named winner in the What the Future (WTF) category of the prestigious 25th Annual SXSW Innovation Awards competition, where the company showcased its new UbiGro® Cover greenhouse film product for enhancing crop yield using fluorescence.

Key Points: 
  • The South by Southwest ® (SXSW®) Innovation Awards recognize the most exciting creative developments in the connected world, celebrating a variety of technological advancements, achievements, and discoveries.
  • From quantum physics to nanotech to bio-engineering moonshots, this category pulls together all the amazing endeavors that make us excited about tomorrow."
  • Later in the week, the United States Department of Agriculture (USDA) awarded UbiQD a Phase I Small Business Innovation and Research (SBIR) grant to develop a glass version of its award-winning UbiGro greenhouse technology.
  • The $175,000 grant will also support plant trials for the new QD-glass product at University of California-Davis later this year.

Keio University Research: Family of ring-like molecules grows

Retrieved on: 
Thursday, March 14, 2024

Now, two such ring-like molecules have been successfully synthesized, with possible applications including sensors and catalysts.

Key Points: 
  • Now, two such ring-like molecules have been successfully synthesized, with possible applications including sensors and catalysts.
  • Cyclic compounds are molecules in which some of the atoms are connected to form a closed ring.
  • Given their key roles in living organisms, porphyrins have inspired the design of synthetic compounds for various applications.
  • Recently, Naoya Kumagai from Keio University and colleagues have succeeded in synthesizing two new members of the porphyrin family, with promising physicochemical properties such as fluorescence and catalytic activity.

Keio University Research: Family of ring-like molecules grows

Retrieved on: 
Thursday, March 14, 2024

Now, two such ring-like molecules have been successfully synthesized, with possible applications including sensors and catalysts.

Key Points: 
  • Now, two such ring-like molecules have been successfully synthesized, with possible applications including sensors and catalysts.
  • Cyclic compounds are molecules in which some of the atoms are connected to form a closed ring.
  • Given their key roles in living organisms, porphyrins have inspired the design of synthetic compounds for various applications.
  • Recently, Naoya Kumagai from Keio University and colleagues have succeeded in synthesizing two new members of the porphyrin family, with promising physicochemical properties such as fluorescence and catalytic activity.

Hybribio Calls for Raising International HPV Awareness

Retrieved on: 
Monday, March 4, 2024

On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.

Key Points: 
  • On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.
  • In this case, raising HPV awareness, getting timely vaccination and high-quality screening together contribute significantly to the prevention of HPV infection and related diseases.
  • Hybribio has developed a complete HPV molecular diagnostic solution covering 14 High-risk HPV GenoArray Diagnostic Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, 14 High-risk HPV E6/E7 mRNA Real-time PCR Kit (PCR with Fluorescent Probe), 21 HPV GenoArray Diagnostic Kit, 37 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 23 HPV Genotyping Real-time PCR Kit, SOX1 and PAX1 Methylation Real-time PCR Kit.
  • Raising international HPV awareness is the very first step against cervical cancer.

Hybribio Calls for Raising International HPV Awareness

Retrieved on: 
Monday, March 4, 2024

On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.

Key Points: 
  • On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.
  • In this case, raising HPV awareness, getting timely vaccination and high-quality screening together contribute significantly to the prevention of HPV infection and related diseases.
  • Hybribio has developed a complete HPV molecular diagnostic solution covering 14 High-risk HPV GenoArray Diagnostic Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, 14 High-risk HPV E6/E7 mRNA Real-time PCR Kit (PCR with Fluorescent Probe), 21 HPV GenoArray Diagnostic Kit, 37 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 23 HPV Genotyping Real-time PCR Kit, SOX1 and PAX1 Methylation Real-time PCR Kit.
  • Raising international HPV awareness is the very first step against cervical cancer.

Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems

Retrieved on: 
Tuesday, February 6, 2024

Bruker Corporation (Nasdaq: BRKR) today announced that it has acquired Spectral Instruments Imaging LLC , a leader in preclinical in-vivo optical imaging systems.

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR) today announced that it has acquired Spectral Instruments Imaging LLC , a leader in preclinical in-vivo optical imaging systems.
  • This acquisition fills a gap in the technology and product portfolio of the Bruker BioSpin Preclinical Imaging (PCI) division, broadening its range of preclinical solutions for disease research.
  • “Spectral Instruments Imaging systems perfectly complement the Bruker Preclinical offering,” said Keith Copeland, the CEO of SII.
  • Their advanced BLI, FLI and X-ray imaging systems complement our portfolio to better serve the diverse needs of our preclinical customers.